Glaxosmithkline Pharmaceuticals has reported results for second quarter ended September 30, 2019.
The company has reported around 5-fold jump in its net profit at Rs 502.79 crore for the quarter under review as compared to Rs 100.77 crore for the same quarter in the previous year. Total income of the company increased by 8.01% at Rs 897.71 crore for Q2FY20 as compared Rs 831.13 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported around 5-fold jump in its net profit at Rs 502.75 crore for the quarter under review as compared to Rs 100.83 crore for the same quarter in the previous year. Total income of the company increased by 8.01% at Rs 897.90 crore for Q2FY20 as compared Rs 831.32 crore for the corresponding quarter previous year.
